确定德克斯梅托米丁转化为克隆的转化因子
Jasmine Stroeder1, Deonne Dersch-Mills1
1Pharmacy Services, Alberta Health Services, Calgary, Alberta, Canada.
概括
这项研究发现,当将重症新生儿从德克斯梅德托米丁输液转换为肠道克隆尼丁时,转换因子约为0.42. 这一因素可以指导临床医生,但由于患者的变化,仔细监测是必不可少的.
科学领域:
- 新生儿药理学 新生儿药理学
- 关键护理医学 关键护理医学
- 药理动力学 药理动力学
背景情况:
- 德克斯梅德托米丁输液在重症新生儿中常见用于镇静.
- 切换到肠道克罗尼丁需要一个明确的转换策略.
- 优化药物转换对于患者的治疗结果至关重要.
研究的目的:
- 在新生儿中,确定从德克斯梅德托米丁过渡到肠内克洛尼丁的转换因子.
- 为管理新生儿镇静的临床医生提供实用指南.
主要方法:
- 在新生儿重症监护室 (NICU) 的43名新生儿进行了回顾性观察性研究.
- 滴定后对德克斯梅德托米丁剂量和随后的肠道克隆尼丁剂量的分析.
- 在转换过程中评估镇静和戒断得分.
主要成果:
- 德克斯梅德托米丁的中位数剂量为17.4mcg/kg/day被转换为7.8mcg/kg/day的中位数肠道克洛尼丁剂量.
- 定位后的转换系数被确定为大约0.42.
- 同时使用阿片类药物在所有接受德克斯梅德托米丁治疗的患者和60%的克隆尼丁转换时被观察到.
结论:
- 确定了0.42的转化因子,可以作为德克斯梅德托米丁转化为克隆尼丁的切换的实际起点.
- 由于患者间的变异性,密切的患者监测和随访至关重要.
- 需要进一步的研究来探索影响这种转换的患者特定因素.
相关概念视频
Renal Failure: Dose Adjustments
71
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
71
Sedatives and Hypnotics Drugs: Miscellaneous Agents
163
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
163
Depolarizing Blockers: Pharmocokinetics
316
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
316
Sedatives and Hypnotics: Overview
315
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
315
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
104
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
104
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
440
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
440


